Vistin Pharma ASA (OSL:VISTN)
Norway
· Delayed Price · Currency is NOK 21.60
+0.10 (0.47%)
At close: Mar 6, 2026
Vistin Pharma ASA Revenue
In the year 2025, Vistin Pharma ASA had annual revenue of 452.29M NOK with 5.31% growth. Vistin Pharma ASA had revenue of 110.74M in the quarter ending December 31, 2025, a decrease of -2.60%.
Revenue
452.29M
Revenue Growth
+5.31%
P/S Ratio
2.06
Revenue / Employee
6.20M
Employees
75
Market Cap
931.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 452.29M | 22.79M | 5.31% |
| Dec 31, 2024 | 429.50M | -8.83M | -2.01% |
| Dec 31, 2023 | 438.33M | 133.48M | 43.78% |
| Dec 31, 2022 | 304.85M | 26.23M | 9.41% |
| Dec 31, 2021 | 278.62M | 24.72M | 9.73% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 699.77M |
| Nordhealth AS | 601.75M |
| Photocure ASA | 532.58M |
| ArcticZymes Technologies ASA | 118.21M |
| Nykode Therapeutics AS | 4.57M |
| Omda AS | 495.69M |
| Lytix Biopharma AS | 377.00K |
| Circio Holding ASA | 123.00K |